Homozygous Familial Hypercholesterolemia Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

By Drug Class (Statins, Cholesterol Absorption Inhibitors, PCSK9 Inhibitors, MTP Inhibitors, ANGPTL3 Inhibitors), By Route of Administration (Oral, Parenteral, Nasal), By Technology (CRISPR-Cas9, RNA Interference, Nanoparticle-Based Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region and Competition

Published	Pages	Publisher	Report code
Oct 2023	188	TechSci Research	ASDR-637925

Published: Oct 2023 - Pages : 188 - Publisher : TechSci Research - Report code : ASDR-637925

1. AstraZeneca PLC
2. Viatris Inc.
3. Teva Pharmaceutical Industries Ltd.
4. Accord Healthcare
5. Changzhou Pharmaceutical Factory
6. Regeneron Pharmaceuticals Inc.
7. Amryt Pharma plc
8. Amgen Inc.
9. Organon Global Inc.
10. CMP Pharma

Hypercholesterolemia Drug - Global Forecast 2024-2030

This report can be of interest as well:

Hypercholesterolemia Drug - Global Forecast 2024-2030

Published: January, 2024 | Report code: ASDR-649600